|
[1] Fabbretti A,Gualerzi C O,Brandi L.How to cope with the quest for new antibiotics.Turin Special Issue:Biochemistry for Tomorrow’s Medicine,2011,585(11):1673-1681.
[2] Tseng H K,Perfect J R.Strategies to manage antifungal drug resistance.Expert Opin Pharmacother, 2011,12(2):241-256.
[3] Shapiro R S,Robbins N,Cowen L E.Regulatory circuitry governing fungal development,drug resistance,and disease.Microbiol Mol Biol Rev,2011,75(2):213-267.
[4] Handelsman J,Rondon M R,Brady S F,et al.Molecular biological access to the chemistry of unknown soil microbes:A new frontier for natural products.Chemistry & Biology,1998,5:245-249.
[5] Imhoff J F,Labes A,Wiese J.Bio-mining the microbial treasures of the ocean: new natural products.Biotechnol Adv,2011,29(5):468-482.
[6] Menzella H G,Reeves C D.Combinatorial biosynthesis for drug development.Curr Opin Microbiol,2007,10(3):238-245.
[7] Zhang Y X,Perry K,Vinci V A.Genome shuffling leads to rapid phenotypic improvement in Bacteria.Nature,2002,415:644-646.
[8] Stephanopoulos G.Metabolic engineering by genome shuffling-two reports on whole-genome shuffling demonstrate the application of combinatorial methods for phenotypic improvement in bacteria.Nature Biotechnology,2002,20(7): 666-668.
[9] Jin Z H, Xu B,Lin S Z,et al.Enhanced production of spinosad in Saccharopolyspora spinosa by genome shuffling.Appl Biochem Biotechnol,2009,159(3):655-663.
[10] Gendy M M,Bondkly A M.Genome shuffling of marine derived bacterium Nocardia sp.ALAA 2000 for improved ayamycin production.Antonie Van Leeuwenhoek,2011,99(4):773-780.
[11] John R P, Gangadharan D,Madhavan Nampoothiri K.Genome shuffling of Lactobacillus delbrueckii mutant and Bacillus amyloliquefaciens through protoplasmic fusion for L-lactic acid production from starchy wastes.Bioresour Technol,2008,99(17):8008-8015.
[12] Wang C,Zhang X L,Chen Z,et al.Strain construction for enhanced production of spinosad via intergeneric protoplast fusion.Canadian Journal of Microbiology,2009,55:1070-1075.
[13] Hopwood D A,Chater,Fresh K F.Approaches to Antibiotic Production.Philosophical Transactions of the Royal Society of London Series B-Biological Sciences,1980,290:313-328.
[14] Jian X,Pang X,Yu Y,et al.Identification of genes necessary for jinggangmycin biosynthesis from Streptomyces hygroscopicus 10-22.Antonie Van Leeuwenhoek,2006,90(1):29-39.
[15] 袁德军,周启.农抗5102产生菌原生质体融合育种的研究Ⅳ.融合子FR-008的验证及其产生新活性物质的分离和鉴别.生物工程学报,1991,7(2):142-147. Yuan D J,Zhou Q.Studies on fusion breeding of protoplasts from antibiotic producing strain 5102Ⅳ.Verification of fusant FR-008,Isolation and characterization of Its new antimicrobial substance.Chinese Journal of Biotechnology,1991,7(2):142-147.
[16] 黄曦,邓子新.多烯大环内酯类抗生素——链霉菌FR-008代谢产物的研究.中国抗生素杂志,1999, 24(5):329-333. Huang X,Deng Z X,Liao R A.Characterization of the hepaene macrolide antibiotic produced by Streptomyces sp.FR-008.Chinese Journal of Antibiotics,1999,24(5):329-333.
[17] Hu Z,Bao K,Zhou X,et al.Repeated polyketide synthase modules involved in the biosynthesis of a heptaene macrolide by Streptomyces sp.FR-008.Mol Microbiol,1994,14(1):163-172.
[18] Chen S,Huang X,Zhou X,et al.Organizational and mutational analysis of a complete FR-008/Candicidin gene cluster encoding a structurally related polyene complex.Chem Bio,2003,10(11):1065-1076.
[19] Wang M Z,Liu S S,Li Y Y,et al.Protoplast mutation and genome shuffling induce the endophytic fungus Tubercularia sp. TF5 to produce new compounds.Current Microbiology,2010,61:254-260.
[20] Li Y,Lu C,Hu Z,et al.Secondary metabolites of Tubercularia sp.TF5,an endophytic fungal strain of Taxus mairei.Nat Prod Res,2009,23(1):70-76.
[21] Ohnishi Y,Ishikawa J,Hara H,et al.Genome sequence of the streptomycin-producing microorganism Streptomyces griseus IFO 13350.Journal of Antibiotics,2008,190(11):4050-4060.
[22] Kudo F,Eguchi T.Biosynthetic genes for aminoglycoside antibiotics.The Journal of Antibiotics,2009,62:471-481.
[23] Yamashita F,Hotta K,Kursawa S,et al.New antibiotic-producing streptomycetes,Selected by antibiotic resistance as a marker.I.New antibiotic production generated by protoplast fusi on treatment between Streptomyces griseus and S.tenjimariensis.Journal of Antibiotics,1985,28:58-63.
[24] 杨毓芬,李焕娄,金文藻,等.新蒽环类化合物F301A的分离鉴别及活性测定.中国抗生素杂志,1998,23(2):104-106. Yang Y F,Li H L,Jin W Z,et al.Isolation,structure elucidation and determination of bioactivity of F301A.Chinese Journal of Antibiotics,1998,23(2):104-106.
[25] Li X M,Novotná J,Vohradsky J,et al.Major proteins related to chlortetracycline biosynthesis in a Streptomyces aureofaciens production strain studied by quantitative proteomics.Appl Microbiol Biotechnol,2001,57:717-724.
[26] Wendell G,Iara R S,Elaine A A,et al.Three new complexes of platinum(II) with doxycycline,oxytetracycline and chlortetracycline and their antimicrobial activity.Journal of the Brazilian Chemical Society,2006,17(8):1627-1633.
[27] 徐京宁,潘铁英,王伟,等.链霉菌种间融合重组子产生的抗生素的分离和化学结构的确认.中国抗生素杂志,1996,21(1):1-4. Xu J N,Pan T Y,Wang W,et al.Isolation and structural assignmenet of the antibiotic produced by recombinant.Chinese Journal of Antibiotics,1996,21(1):1-4.
[28] Fleck W F,Schlegel B,Ihn W.New anthracycline antibiotics produced by interspecific recombinants of streptomycetes.IV.Antimicrobial Activity of Iremycin.Z Allg Mikrobiol,1982,22(5):349-353.
[29] Carolina C M,Tania E C Z,Gabriela R E.Penicillin and cephalosporin production:a historical perspective.Rev Latinoam Microbiol,2007,49:88-98.
[30] Chen C C,Feng Y S,Chyau C C,et al.Method for producing novel beta-lactam antibiotic from protoplast fusion strain.US,20050054031A1,2005-3-10.
[31] Burg R W,Miller B M,Baker E E,et al.Avermectins,new family of potent anthelmintic agents:producing organism and fermentation.Antimicrob Agents Chemother,1979,15(3):361-367.
[32] Kim K R,Kim T J,Suh J W.The gene cluster for spectinomycin biosynthesis and the aminoglycoside-resistance function of spcM in Streptomyces spectabilis.Curr Microbiol,2008, 57(4):371-374.
[33] 许国旺,路鑫,杨胜利.代谢组学研究进展.中国医学科学院学报,2007,29(6):701-711. Xu G W,Lu X,Yang S L.Recent advances in metabonomics.Acta Academiae Medicinae Sinicae,2007,29(6):701-711.
[34] Nicholson J K,Lindon J C,Systems biology:metabonomics.Nature,2008,455:1054-1056.
[35] Lindon J C,Holmes E,Nicholson J K.Metabonomics and its role in drug development and disease diagnosis.Expert Rev Mol Diagn,2004,4(2):189-199.
|
